Compare LXEO & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LXEO | BWFG |
|---|---|---|
| Founded | 2017 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.8M | 417.5M |
| IPO Year | 2023 | 2014 |
| Metric | LXEO | BWFG |
|---|---|---|
| Price | $5.16 | $52.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $18.44 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 667.0K | 25.4K |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.52% |
| EPS Growth | 39.81 | ★ 261.79 |
| EPS | N/A | ★ 1.41 |
| Revenue | $654,000.00 | ★ $2,826,000.00 |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | N/A | $6.21 |
| P/E Ratio | ★ N/A | $37.20 |
| Revenue Growth | N/A | ★ 43.96 |
| 52 Week Low | $2.72 | $34.20 |
| 52 Week High | $10.99 | $53.86 |
| Indicator | LXEO | BWFG |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 56.62 |
| Support Level | $4.95 | $50.15 |
| Resistance Level | $6.26 | $53.67 |
| Average True Range (ATR) | 0.38 | 0.90 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 36.34 | 88.34 |
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.